Digest Network Come funziona
Network
/
Società
Ro
Non verificato

Rocket Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaMedicina - VarieSalute

28 comunicati stampa

Guarda tutti i comunicati
25/11/2025
Eventi
Web e Social Network
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Cardiologia
Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
06/11/2025
Mercato azionario
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
14/10/2025
Oncologia
Salute
Igiene alimentare
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
10/10/2025
Biotecnologia
Finanza
Salute
Associazioni/Professionisti
Farmaceutica
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
28/08/2025
Scienza
Biotecnologia
Sanità
Salute
Farmaceutica
Eventi
Web e Social Network
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
20/08/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
Industria
Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
07/08/2025
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Farmaceutica
Cardiologia
Mercato azionario
Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
24/07/2025
Scienza
Biotecnologia
Medicina - Varie
Biologia
Cardiologia
Salute
Farmaceutica
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
17/07/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
Industria
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
30/06/2025
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
Industria
Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy
Fonte
Rocket Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0